期刊文献+

细胞色素P450的基因多态性与药物代谢 被引量:21

Genetic polymorphism of cytochrome P450 and drug metabolism
下载PDF
导出
摘要 细胞色素P450(cytochrome P450,CYP)是重要的药物代谢酶,参与催化多种内源和外源化合物,特别是多种临床药物的生物转化。CYP存在广泛的基因多态性和表型多态性,使其对于各种化合物的代谢存在统计学个体差异。核受体是配体依赖性转录因子超家族,与药物代谢过程中的基因表达调控密切相关,被外源物质活化后诱导或抑制CYP基因的表达。现综述CYP与药物代谢、CYP的基因多态性、CYP表达的诱导机制、核受体及其配体诱导CYP表达及近年研究CYP450的各种实验方法。 Cytochrome P450 (CYP) is a family of the body's more powerful detox enzymes that involves in the biotransformation of various endogenous and exogenous compounds including clinical drugs. Genetic and phenotypic polymorphism of CYP results in the individual differences of xenobiotic metabolisms. Nuclear receptors belong to a superfamily of ligand-activated transcription factors, which are involved in regulating gene expression in drug metabolic processes by inducing or inhibiting the expression of CYP. This article reviews CYP and drug metabolic, genetic polymorphism of CYP, inducing mechanism of CYP expression, nuclear receptors with their ligands inducing the expression of CYP and research methods of CYP in passing years.
出处 《中国新药杂志》 CAS CSCD 北大核心 2007年第7期510-515,共6页 Chinese Journal of New Drugs
关键词 细胞色素P450 药物代谢 基因多态性 核受体 cytochrome P450 drug metabolism genetic polymorphism nuclear receptor
  • 相关文献

参考文献26

  • 1杨宝峰.药理学[M](第6版)[M].北京:人民卫生出版社,2005.127.
  • 2徐月萍,吴伯镛.细胞色素P450酶系与代谢性药物相互作用[J].现代实用医学,2002,14(10):557-558. 被引量:7
  • 3韩艳波,冯向先,李佩珍,牛志高.CYP1A1、GSTM1基因多态性与食管癌遗传易感性[J].中国公共卫生,2005,21(1):3-6. 被引量:20
  • 4夏雪雁,彭仁琇.CYP2A6多态性对尼古丁代谢及烟草依赖行为的影响[J].药学学报,2004,39(9):758-763. 被引量:3
  • 5CHOI JY, LEE KM, CHO SH, et al. CYP2E1 and NQO1 genotypes, smoking and bladder cancer [ J ]. Pharmacogenetics, 2003, 13(6) : 349 -355.
  • 6HADFIELD RM, MANEK S, WEEKS DE, et al. Linkage and association studies of the relationship between endometfiosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1 [J]. Mol Hum Reprod, 2001, 7(11) : 1073 - 1078.
  • 7金剑,肖忠革,陈慧瑾.细胞色素氧化酶CYP1A2基因多态性及其对代谢的影响[J].中国临床药学杂志,2005,14(1):60-62. 被引量:7
  • 8LEE S, KIM JM, CHUNG CS, et al. Polymorphism in CYP2C9 as a non-critical factor of warfarin dosage adjustment in Korean patients [ J ]. Arch Pharm Res, 2003, 26 ( 11 ) : 967 - 972.
  • 9YASAR U, LUNDQREN S, ELIASSON E, et al. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms[J]. Biochem Biophys Res Commun, 2002, 299(1) : 25 -28.
  • 10BLAISDELL J, MOHRENWEISER H, JACKSON J, et al. Identification and functional characterization of new potentially defective alleles of human CYP2C19 [ J ]. Pharmacogenetics, 2002, 12(9) : 701 -711.

二级参考文献138

  • 1Ai Ping BAI,Zong Ru GUO,Wen Hui HU,Fang SHEN,Gui Fang CHENG.Design,Synthesis and in vitro Evaluation of a New Class of Novel Cyclooxygenase-2 Inhibitors:3,4-diaryl-3-pyrrolin-2-ones[J].Chinese Chemical Letters,2001,12(9):775-778. 被引量:7
  • 2许振华,周宏灏.细胞色素氧化酶P4501A2与药物代谢[J].中国临床药理学杂志,1996,12(2):115-121. 被引量:22
  • 3Piegorsch WW,Weinberg CR,Taylor JA.Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies.Stat Med,1994,13:153-162.
  • 4Yang Q,Khoury MJ,Sun F,et al.Case-only design to measure gene-gene interaction.Epidemiology,1999,10:167-170.
  • 5Guillemette C,Ritter JK,Auyeung DJ,et al.Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus:functional consequences of three novel missense mutations in the human UGT1A7 gene.Pharmacogenetics,2000,10:629-644.
  • 6Sivaraman L,Leatham MP,Yee J,et al.CYP1A1 genetic polymorphisms and in situ colorectal cancer.Cancer Res,1994,54:3692-3695.
  • 7Song N,Tan W,Xing D,et al.CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking:a case-control study in China.Carcinogenesis,2001,22:11-16.
  • 8Ando M,Ando Y,Sekido Y,et al.Genetic polymorphisms of the UDP-glucuronosyltransferase 1A7 gene and irinotecan toxicity in Japanese cancer patients.Jpn J Cancer Res,2002,93:591-597.
  • 9de Jong MM,Nolte IM,te Meerman GJ,et al.Low-penetrance genes and their involvement in colorectal cancer susceptibility.Cancer Epidemiol Biomarkers Prev,2002,11:1332-1352.
  • 10Zhong S,Wyllie AH,Barnes D,et al.Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder,breast,and colon cancer.Carcinogenesis,1993,14:1821-1824.

共引文献110

同被引文献263

引证文献21

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部